Categories: News

SenseAnywhere Provides COVID-19 Vaccine Monitoring in Europe

PEPPERELL, Mass., Dec. 3, 2020 /PRNewswire-PRWeb/ — SenseAnywhere, a fully automated, wireless temperature monitoring system, will be used to monitor the temperature conditions of the COVID-19 vaccines in Europe in storage and transport. To monitor the conditions, SenseAnywhere will use its AiroSensors in combination with the PT100 smart probes ensuring safe distribution across Europe. Masy BioServices is proud to be the exclusive North American distributor of SenseAnywhere temperature monitoring system.

To learn more, visit our website http://www.masy.com/senseanywhere, call 978-433-6279, or email sales@masy.com to talk with a SenseAnywhere expert.

SenseAnywhere is the ideal monitoring system for all temperature conditions required for vaccine transport and storage. View your data through SenseAnywhere’s graphical interface from your computer or smart device 24-7, or use the API (Application Programming Interface) to integrate with your application. A ‘Plug and Play’ solution, SenseAnywhere’s calibrated loggers are simple to set up and offered at an affordable price point, while providing an impressive accuracy of +/- 0.1˚C.

About SenseAnywhere

SenseAnywhere manufactures very accurate, easy to use and long-lasting dataloggers, enabling fully automated temperature monitoring during storage or transport of temperature-sensitive products. The monitoring and mapping solutions are being used in all kinds of industries, among which are Food, Pharma and Logistics, all over the world.

About Masy BioServices

Masy BioServices has provided quality solutions to the life sciences community for over 35 years through an array of services, including calibration of primary standards and critical test equipment; validation and IQ/OQ/PQ of environmental chambers, autoclaves, and thermal warehouse mapping; and lab equipment rentals and sales. Masy has a premier cGMP biorepository, offering secure and tightly controlled temperature storage from -196˚C to 70˚C, including all ICH stability conditions, for various materials including vaccines, biopharmaceuticals, cell banks, tissues, compounds, and medical devices.

Follow us on LinkedIn – Masy BioServices

Press Contact:
Kristine LeBlanc
Senior Marketing Manager
Masy BioServices
Kristine.LeBlanc@masy.com
978-433-6279 x 1458

Media Contact

Kristine LeBlanc, Masy BioServices, +1 9784336279 Ext: 1458, kristine.leblanc@masy.com

Twitter, Facebook

 

SOURCE Masy BioServices

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

13 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

16 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

16 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

16 hours ago